Kimberly Kho, UT Southwestern Medical Center
Jin Hee Kim, Columbia Irving Medical Center - New York Presbyterian Hospital
Kristen Pepin, Weill Cornell Medicine
Sandra Laveaux, University of Chicago
![Ayman Al-Hendy](http://assets.swoogo.com/uploads/thumb/3100211-6539e6b175ac0.jpg)
![Kimberly Kho](http://assets.swoogo.com/uploads/thumb/3100366-6539ee272401f.jpg)
![Jin Hee Kim](http://assets.swoogo.com/uploads/thumb/3100367-6539ee3678462.png)
This course will offer surgeons with minimally invasive experience the opportunity to review current and evolving treatment options for women with fibroids, as it relates to feasibility, sustainability, and fertility. The course will focus on the current evidence available for traditional and novel therapeutics, including the newer FDA-approved technologies. The course will discuss best practices and ways to optimize fertility care and overcome challenging clinical situations for the various fibroid treatment options that will be covered. The course will also dig into the future directions for research for next generation therapeutics. This course applies to the global AAGL audience and offers techniques aimed to promote and sustain safe and successful minimally invasive fibroid treatment.
Learning Objectives: At the end of this course, the participant will be able to: 1)Discuss the various traditional and novel therapeutics and ascertain who may be the best candidates for each option; 2) Develop a strategy to counsel patients regarding fertility outcomes after RFA/UAE; 3) Apply techniques to optimize fertility at the time of myomectomy and to prevent fertility complications; 4) Utilize optimal surgical preparation and techniques to push the envelope during minimally invasive myomectomy; and 5) Explore current and future directions in fibroid research through collaborations with basic science and translational research experts.
PRESENTATION SCHEDULE
2:00 Welcome, Introduction and Course Overview
2:05 GnRH Antagonists in Our Toolbox: Who Are the Best Candidates and What Is the Data? How to Incorporate Them into Clinical Practice
A. Al-Hendy
2:30 Fertility and Pregnancy Outcome after RFA and UAE: Is It Safe and How Do We Counsel Our Patients?
K.A. Kho
2:55 Optimizing Fertility at the Time of Laparoscopic/Robotic Myomectomy: Preoperative Considerations and Preventing Complications
J.H. Kim
3:20 Hysteroscopic Myomectomy: How Big Is Too Big to Remove Hysteroscopically in the Modern Era?
K.J. Pepin
3:45 Where Is the Future of Fibroid Treatment? an Invitation to Challenge the Status Quo
S. Laveaux
4:10 Questions & Answers
4:29 Adjourn
201 Rep. John Lewis Way S
Nashville, TN 37203
United States